Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 μg levonorgestrel and 20 μg ethinyl estradiol (Alesse®)

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 5 II, 1999, Pages

  Archer, D F ^a   Maheux, R ^a   DelConte, A ^a   O'Brien, F B ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Alesse; Breakthrough bleeding; Ethinyl estradiol; Levonorgestrel; Oral contraceptive

Indexed keywords

ETHINYLESTRADIOL PLUS LEVONORGESTREL; UNCLASSIFIED DRUG;

ACNE; ADULT; AFFECTIVE NEUROSIS; AMENORRHEA; ARTICLE; BREAKTHROUGH BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MENORRHAGIA; MENSTRUAL CYCLE; METRORRHAGIA; MIGRAINE; MULTICENTER STUDY; NAUSEA; NORMAL HUMAN; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PREGNANCY RATE; PRIORITY JOURNAL; SEXUAL DYSFUNCTION; SPOTTING;

EID: 0032755922     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9378(99)70362-5     Document Type: Article

References (8)

1. IC Arnt A Ferrari JN Sartoretto TB Woutersz Low-dose combination oral contraceptives: a controlled clinical study of three different norgestrel-ethinyl estradiol ratios Fertil Steril 28 1997 549 553
2. JN Sartoretto JC Ortega-Recio Clinical evaluation of a low dosage estrogen-progesterone association (100 μg of d-norgestrel and 20 μg of ethinyl estradiol) Rev Bras Clin Ther 3 1974 399 404
3. DF Archer R Maheux A DelConte FB O’Brien A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 μg and ethinyl estradiol 20 μg North American Levonorgestrel Study Group (NALSG) Contraception 55 1997 139 144
4. C Tietze S Lewit Statistical evaluation of contraceptive methods Clin Obstet Gynecol 17 1974 121 138
5. JF Schindler HU Feldmann 20 μg ethinylestradiol/100 μg levonorgestrel: mit dem neuen oralen contrazeptivum Miranova ist die palette levonorgestrel-haltiger ovulationshemmer vervollständigt worden Gyne Extra 17 1996 179 182
6. J Endrikat U Müller B Düsterberg A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance Contraception 55 1997 131 137
7. R Bannemerschult JP Hanker C Wünsch P Fox M Albring K Brill A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles Contraception 56 1997 285 290
8. L Speroff A DeCherney Evaluation of a new generation of oral contraceptives. The Advisory Board for the New Progestins Obstet Gynecol 81 1998 1034 1047